Hackensack Meridian Health
Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study asks: do all struggling newborns need breathing machines? Results expected Dec 2026 (estimated)
- ER Check-Ups could boost lung cancer screening rates Results expected Dec 2026 (estimated)
- Can a prostate drug stop Post-Surgery urinary problems? Results expected Mar 2027 (estimated)
- Umbilical cord wrap may help men recover faster after prostate cancer surgery Results expected Apr 2027 (estimated)
- Simple blood test could decide best therapy for advanced lung cancer Results expected Apr 2027 (estimated)
-
New clinic aims to keep heart failure patients out of the hospital
Disease control Stopped earlyThis study tests a multidisciplinary clinic that provides heart failure patients with educational videos, a self-management kit, and follow-up phone calls after hospital discharge. The goal is to reduce 30-day readmission rates and improve patient satisfaction. The trial enrolls …
Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Sep 21, 2026 23:00 UTC
-
Experimental combo for Graft-Versus-Host disease fails to enroll
Disease control Stopped earlyThis study tested a mix of drugs (cyclophosphamide, sirolimus, low-dose IL-2, and azacitidine) to treat severe graft-versus-host disease that didn't respond to steroids. Only 3 patients were enrolled before the trial was stopped early. The goal was to see if the treatment could c…
Phase 1/2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Stem cell transplant study halted early: which prep works best?
Disease control Stopped earlyThis study tested two different drug combinations given before a stem cell transplant for people with myeloid blood cancers like leukemia. One group got fludarabine and busulfan, the other got those drugs plus low-dose total body irradiation. The goal was to see which regimen led…
Phase 3 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Immunotherapy combo after transplant shows promise for High-Risk blood cancers
Disease control Stopped earlyThis study tested whether giving two immunotherapy drugs (nivolumab and ipilimumab) after a stem cell transplant could safely help control high-risk multiple myeloma and lymphoma. It involved 46 adults aged 18-80 whose cancer was at high risk of coming back. The main goal was to …
Phase 1/2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Stem cell study for older myeloma patients halted early
Disease control Stopped earlyThis study looked at two different high-dose chemotherapy treatments for people aged 65 and older with multiple myeloma, a type of blood cancer. Participants received either the standard chemotherapy (melphalan) or a combination of melphalan and another drug (bortezomib) before a…
Phase 2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Blood pressure drug tested to prevent transplant complication
Prevention Stopped earlyThis pilot study tested the blood pressure drug telmisartan (Micardis) to prevent acute graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers. The trial aimed to enroll 60 participants but was terminated early with 32. Researchers tracked s…
Sponsor: Hackensack Meridian Health • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Diabetes education tailored for hispanic men shows promise in small study
Symptom relief Stopped earlyThis study tested whether a five-week culturally tailored diabetes education program could help Hispanic men aged 18-64 with type 2 diabetes improve their self-management behaviors like healthy eating, physical activity, and medication use. The program was designed specifically f…
Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a simple pill duo make medical abortion more comfortable?
Symptom relief Stopped earlyThis early-stage trial tested whether taking ibuprofen (a pain reliever) and ondansetron (an anti-nausea drug) before a medical abortion could reduce side effects and improve patient satisfaction. The study enrolled 8 healthy women undergoing early medical abortion (up to 70 days…
Early phase 1 • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Antibiotic resistance explored in myeloma stem cell transplants
Knowledge-focused Stopped earlyThis study aimed to find out how common antibiotic resistance is in multiple myeloma patients receiving a stem cell transplant. Researchers planned to collect data from 124 adults to help design future studies on preventing infections. The study was stopped early, so results are …
Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Tablet teaching for diabetes: a High-Tech hope for new patients?
Knowledge-focused Stopped earlyThis study tested whether using a bedside tablet with interactive education modules helps people newly diagnosed with type 1 diabetes learn more than standard paper-based materials. The trial planned to enroll 28 patients but was terminated early. Researchers measured diabetes kn…
Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC